Melanoma-associated leukoderma: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Melanoma-associated leukoderma | |||
| synonyms = | |||
| field = [[Dermatology]], [[Oncology]] | |||
| symptoms = [[Hypopigmentation]] of the skin | |||
| complications = | |||
| onset = | |||
| duration = | |||
| types = | |||
| causes = Immune response to [[melanoma]] | |||
| risks = | |||
| diagnosis = Clinical examination, [[biopsy]] | |||
| differential = [[Vitiligo]], other causes of leukoderma | |||
| prevention = | |||
| treatment = Treatment of underlying [[melanoma]] | |||
| medication = | |||
| prognosis = Depends on melanoma progression | |||
| frequency = Rare | |||
}} | |||
'''Melanoma-associated leukoderma''' is a [[skin condition]] characterized by the loss of [[skin pigmentation]] in patients diagnosed with [[melanoma]], a type of [[skin cancer]]. This condition is also known as '''vitiligo-like leukoderma''' due to its similarity with [[vitiligo]], a skin disorder that causes the loss of skin color in blotches. | '''Melanoma-associated leukoderma''' is a [[skin condition]] characterized by the loss of [[skin pigmentation]] in patients diagnosed with [[melanoma]], a type of [[skin cancer]]. This condition is also known as '''vitiligo-like leukoderma''' due to its similarity with [[vitiligo]], a skin disorder that causes the loss of skin color in blotches. | ||
==Etiology== | ==Etiology== | ||
The exact cause of melanoma-associated leukoderma is not fully understood. However, it is believed to be an [[immune response]] to the presence of melanoma cells in the body. The immune system attacks the melanoma cells, but also targets normal [[melanocytes]], the cells responsible for producing [[melanin]], the pigment that gives color to the skin, hair, and eyes. | The exact cause of melanoma-associated leukoderma is not fully understood. However, it is believed to be an [[immune response]] to the presence of melanoma cells in the body. The immune system attacks the melanoma cells, but also targets normal [[melanocytes]], the cells responsible for producing [[melanin]], the pigment that gives color to the skin, hair, and eyes. | ||
==Symptoms== | ==Symptoms== | ||
The primary symptom of melanoma-associated leukoderma is the appearance of white patches on the skin. These patches can appear anywhere on the body but are most commonly found on the face, hands, and feet. The loss of pigmentation can also affect the hair and eyes, leading to premature graying or changes in eye color. | The primary symptom of melanoma-associated leukoderma is the appearance of white patches on the skin. These patches can appear anywhere on the body but are most commonly found on the face, hands, and feet. The loss of pigmentation can also affect the hair and eyes, leading to premature graying or changes in eye color. | ||
==Diagnosis== | ==Diagnosis== | ||
Diagnosis of melanoma-associated leukoderma is typically made through a combination of [[physical examination]], patient history, and [[skin biopsy]]. The biopsy can confirm the presence of melanoma cells and the absence of melanocytes in the affected areas. | Diagnosis of melanoma-associated leukoderma is typically made through a combination of [[physical examination]], patient history, and [[skin biopsy]]. The biopsy can confirm the presence of melanoma cells and the absence of melanocytes in the affected areas. | ||
==Treatment== | ==Treatment== | ||
Treatment for melanoma-associated leukoderma primarily focuses on treating the underlying melanoma. This can include [[surgery]], [[chemotherapy]], [[radiation therapy]], and [[immunotherapy]]. In some cases, treatments to restore skin color, such as [[topical corticosteroids]], [[psoralen plus ultraviolet A (PUVA) therapy]], and [[tattooing]], may be used. | Treatment for melanoma-associated leukoderma primarily focuses on treating the underlying melanoma. This can include [[surgery]], [[chemotherapy]], [[radiation therapy]], and [[immunotherapy]]. In some cases, treatments to restore skin color, such as [[topical corticosteroids]], [[psoralen plus ultraviolet A (PUVA) therapy]], and [[tattooing]], may be used. | ||
==Prognosis== | ==Prognosis== | ||
The prognosis for melanoma-associated leukoderma varies depending on the stage and aggressiveness of the underlying melanoma. In some cases, the appearance of leukoderma can be a positive sign, indicating that the body's immune system is actively fighting the melanoma cells. | The prognosis for melanoma-associated leukoderma varies depending on the stage and aggressiveness of the underlying melanoma. In some cases, the appearance of leukoderma can be a positive sign, indicating that the body's immune system is actively fighting the melanoma cells. | ||
==See also== | ==See also== | ||
* [[Melanoma]] | * [[Melanoma]] | ||
| Line 27: | Line 36: | ||
* [[Skin cancer]] | * [[Skin cancer]] | ||
* [[Immunotherapy]] | * [[Immunotherapy]] | ||
[[Category:Skin conditions]] | [[Category:Skin conditions]] | ||
[[Category:Melanoma]] | [[Category:Melanoma]] | ||
Latest revision as of 23:30, 3 April 2025
| Melanoma-associated leukoderma | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Hypopigmentation of the skin |
| Complications | |
| Onset | |
| Duration | |
| Types | |
| Causes | Immune response to melanoma |
| Risks | |
| Diagnosis | Clinical examination, biopsy |
| Differential diagnosis | Vitiligo, other causes of leukoderma |
| Prevention | |
| Treatment | Treatment of underlying melanoma |
| Medication | |
| Prognosis | Depends on melanoma progression |
| Frequency | Rare |
| Deaths | N/A |
Melanoma-associated leukoderma is a skin condition characterized by the loss of skin pigmentation in patients diagnosed with melanoma, a type of skin cancer. This condition is also known as vitiligo-like leukoderma due to its similarity with vitiligo, a skin disorder that causes the loss of skin color in blotches.
Etiology[edit]
The exact cause of melanoma-associated leukoderma is not fully understood. However, it is believed to be an immune response to the presence of melanoma cells in the body. The immune system attacks the melanoma cells, but also targets normal melanocytes, the cells responsible for producing melanin, the pigment that gives color to the skin, hair, and eyes.
Symptoms[edit]
The primary symptom of melanoma-associated leukoderma is the appearance of white patches on the skin. These patches can appear anywhere on the body but are most commonly found on the face, hands, and feet. The loss of pigmentation can also affect the hair and eyes, leading to premature graying or changes in eye color.
Diagnosis[edit]
Diagnosis of melanoma-associated leukoderma is typically made through a combination of physical examination, patient history, and skin biopsy. The biopsy can confirm the presence of melanoma cells and the absence of melanocytes in the affected areas.
Treatment[edit]
Treatment for melanoma-associated leukoderma primarily focuses on treating the underlying melanoma. This can include surgery, chemotherapy, radiation therapy, and immunotherapy. In some cases, treatments to restore skin color, such as topical corticosteroids, psoralen plus ultraviolet A (PUVA) therapy, and tattooing, may be used.
Prognosis[edit]
The prognosis for melanoma-associated leukoderma varies depending on the stage and aggressiveness of the underlying melanoma. In some cases, the appearance of leukoderma can be a positive sign, indicating that the body's immune system is actively fighting the melanoma cells.
See also[edit]
This article is a skin-condition stub. You can help WikiMD by expanding it!
